CareLit CareLitFachliteratur für Gesundheitsberufe
CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine

IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER

Nurşin Agüloğlu, Ayşegül Aksu, Murat Akyol, Nuran Katgı, Tuğçe Çiftçi Doksöz · Nuklearmedizin - NuclearMedicine · Ausgabe 06/2022 · S. 433-439

DOI 10.1055/a-1868-4918

Bibliografische Angaben

Nachweis in CareLit

Autor:innenNurşin Agüloğlu, Ayşegül Aksu, Murat Akyol, Nuran Katgı, Tuğçe Çiftçi Doksöz
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe06/2022
Jahrgang / SeitenJg. 61 · S. 433-439

Kernaussage aus der Literatur

Abstract-Vorschau

Abstract Objective Identification of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) mutation types is of great importance before treatment with tyrosine kinase inhibitors (TKIs). Radiomics is a new strategy for noninvasively predicting the genetic status of cancer. We aimed to evaluate the predictive power of 18F-FDG PET/CT-based radiomic features for mutational status before treatment…

Zitieren

Zitierempfehlung

Nurşin Agüloğlu, Ayşegül Aksu, Murat Akyol, Nuran Katgı, Tuğçe Çiftçi Doksöz (2022) IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER. Nuklearmedizin - NuclearMedicine, 61 (06), 433-439. https://doi.org/10.1055/a-1868-4918

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur